Induction of Heat Shock Proteins in the Therapy of Type 2 Diabetes and Metabolic Syndrome

por Hooper, Philip L.
Publicado 2014

Hypothesis to explain poor outcomes in the ALLHAT and V-HeFT trials: decreased expression of heat shock proteins

por Hooper, Philip L
Publicado 2001

COVID-19 and heme oxygenase: novel insight into the disease and potential therapies

por Hooper, Philip L.
Publicado 2020

Correction to: COVID-19 and heme oxygenase: novel insight into the disease and potential therapies

por Hooper, Philip L.
Publicado 2020

Heme oxygenase agonists—fluvoxamine, melatonin—are efficacious therapy for Covid-19

por Hooper, Philip L.
Publicado 2021

The ophthalmic surgical backlog associated with the COVID-19 pandemic: a population-based and microsimulation modelling study

por Felfeli, Tina, Ximenes, Raphael, Naimark, David M.J., Hooper, Philip L., Campbell, Robert J., El-Defrawy, Sherif R., Sander, Beate
Publicado 2021

Effect of HEAT therapy in patiEnts with type 2 Diabetes mellitus (HEATED): protocol for a randomised controlled trial

por Sebők, Judit, Édel, Zsófia, Dembrovszky, Fanni, Farkas, Nelli, Török, Zsolt, Balogh, Gábor, Péter, Mária, Papp, Ildiko, Balogi, Zsolt, Nusser, Nóra, Péter, Iván, Hooper, Philip, Geiger, Paige, Erőss, Bálint, Wittmann, István, Váncsa, Szilárd, Vigh, László, Hegyi, Péter
Publicado 2022

Dihydropyridine Derivatives Modulate Heat Shock Responses and have a Neuroprotective Effect in a Transgenic Mouse Model of Alzheimer’s Disease

por Kasza, Ágnes, Hunya, Ákos, Frank, Zsuzsa, Fülöp, Ferenc, Török, Zsolt, Balogh, Gábor, Sántha, Miklós, Bálind, Árpád, Bernáth, Sándor, Blundell, Katie L.I.M., Prodromou, Chrisostomos, Horváth, Ibolya, Zeiler, Hans-Joachim, Hooper, Philip L., Vigh, László, Penke, Botond
Publicado 2016